GGrantIndex
← Leaderboards

Debika Bhattacharya

University Of California Los Angeles

$3,936,355
Attributed
$3,936,355
Total exposure
3
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $808.2K · FY200818
$1M$750K$500K$250K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18

Funding mix

By agency

NIH$3,936,355 · 3

By mechanism

R01$3,220,462 · 2
K23$715,893 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of California Los Angeles

Same institution · by research overlap

Others in their field

Top investigators on “Acquired Immunodeficiency Syndrome

Research focus

Acquired Immunodeficiency SyndromeAntiviral TherapyAffectResistanceResourcesAreaHepatitis BLamivudineAntiretroviral TherapyProgramsHepatitis B VirusViral Load ResultAntiviral AgentsAfricanHiv InfectionsAfricaPublic Health Medicine (Field)RegimenUnited States National Institutes Of HealthCd4 Lymphocyte CountMono-SInfectionViral HepatitisAsia

Grant awards (14)

Impact of HIV PMTCT Interventions on HIV/HBV Co-infected Women and Their Infants$412,630
R01 · FY2018 · HD · contact PI
Impact of HIV PMTCT Interventions on HIV/HBV Co-infected Women and Their Infants$451,034
R01 · FY2017 · HD · contact PI
Impact of HIV PMTCT Interventions on HIV/HBV Co-infected Women and Their Infants$421,873
R01 · FY2016 · HD · contact PI
Lamivudine and its Impact on Perinatal HBV Transmission in HIV/HBV Coinfection$386,333
R01 · FY2016 · AI · contact PI
Lamivudine and its Impact on Perinatal HBV Transmission in HIV/HBV Coinfection$386,315
R01 · FY2015 · AI · contact PI
Lamivudine and its Impact on Perinatal HBV Transmission in HIV/HBV Coinfection$386,296
R01 · FY2014 · AI · contact PI
Lamivudine and its Impact on Perinatal HBV Transmission in HIV/HBV Coinfection$369,116
R01 · FY2013 · AI · contact PI
Lamivudine and its Impact on Perinatal HBV Transmission in HIV/HBV Coinfection$406,865
R01 · FY2012 · AI · contact PI
HIV and Hepatitis B Coinfection: Hepatitis B Genotype, Resistance and Outcomes$123,390
K23 · FY2012 · AI · contact PI
HIV and Hepatitis B Coinfection: Hepatitis B Genotype, Resistance and Outcomes$123,390
K23 · FY2011 · AI · contact PI
HIV and Hepatitis B Coinfection: Hepatitis B Genotype, Resistance and Outcomes$123,390
K23 · FY2010 · AI · contact PI
HIV and Hepatitis B Coinfection: Hepatitis B Genotype, Resistance and Outcomes$123,390
K23 · FY2009 · AI · contact PI
HIV and Hepatitis B Coinfection: Hepatitis B Genotype, Resistance and Outcomes$98,943
K23 · FY2009 · AI · contact PI
HIV and Hepatitis B Coinfection: Hepatitis B Genotype, Resistance and Outcomes$123,390
K23 · FY2008 · AI · contact PI